Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanne Vestergaard

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
British Journal of Haematology|October 12, 2013
Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population-based cohort studySarah Farmer, Erzsébet Horváth-Puhó, Hanne Vestergaard, et al.
Dermatology (Basel, Switzerland)|June 19, 2013
KIT D816V mutation-positive cell fractions in lesional skin biopsies from adults with systemic mastocytosisThomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, et al.
American Journal of Hematology|January 21, 2014
Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosisThomas Kristensen, Hanne Vestergaard, Carsten Bindslev-Jensen, et al.
British Journal of Haematology|May 20, 2016
Comparison of gDNA-based versus mRNA-based KIT D816V mutation analysis reveals large differences between blood and bone marrow in systemic mastocytosisThomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, et al.
Allergy|December 29, 2019
Clinical validation of a new commercial highly sensitive KIT D816V mutation analysis in mastocytosisThomas Kristensen, Hanne Vestergaard, Carsten Bindslev-Jensen, et al.
European Journal of Haematology|June 23, 2015
Targeted ultradeep next-generation sequencing as a method for KIT D816V mutation analysis in mastocytosisThomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, et al.
European Journal of Haematology|April 4, 2012
Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosisThomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, et al.
European Journal of Haematology|April 30, 2013
Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosisThomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, et al.
The Journal of Allergy and Clinical Immunology|May 22, 2012
Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutationsSigurd Broesby-Olsen, Thomas Kielsgaard Kristensen, Michael Boe Møller, et al.
Infectious Diseases (London, England)|August 27, 2015
Clinical characteristics and laboratory findings in Danish children hospitalized with primary Epstein-Barr virus infectionSofie Kathrine Topp, Vibeke Rosenfeldt, Hanne Vestergaard, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|October 12, 2013
Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population-based cohort studySarah Farmer, Erzsébet Horváth-Puhó, Hanne Vestergaard, et al.
Dermatology (Basel, Switzerland)|June 19, 2013
KIT D816V mutation-positive cell fractions in lesional skin biopsies from adults with systemic mastocytosisThomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, et al.
American Journal of Hematology|January 21, 2014
Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosisThomas Kristensen, Hanne Vestergaard, Carsten Bindslev-Jensen, et al.
British Journal of Haematology|May 20, 2016
Comparison of gDNA-based versus mRNA-based KIT D816V mutation analysis reveals large differences between blood and bone marrow in systemic mastocytosisThomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, et al.
Allergy|December 29, 2019
Clinical validation of a new commercial highly sensitive KIT D816V mutation analysis in mastocytosisThomas Kristensen, Hanne Vestergaard, Carsten Bindslev-Jensen, et al.
European Journal of Haematology|June 23, 2015
Targeted ultradeep next-generation sequencing as a method for KIT D816V mutation analysis in mastocytosisThomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, et al.
European Journal of Haematology|April 4, 2012
Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosisThomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, et al.
European Journal of Haematology|April 30, 2013
Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosisThomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, et al.
The Journal of Allergy and Clinical Immunology|May 22, 2012
Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutationsSigurd Broesby-Olsen, Thomas Kielsgaard Kristensen, Michael Boe Møller, et al.
Infectious Diseases (London, England)|August 27, 2015
Clinical characteristics and laboratory findings in Danish children hospitalized with primary Epstein-Barr virus infectionSofie Kathrine Topp, Vibeke Rosenfeldt, Hanne Vestergaard, et al.
Pageof 7